Clinical Trial Update: A Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics/Pharmacodynamics of BAYQ3939 in Patients With Bacterial Pneumonia [Phase 3]

View source ↗

Summary

The document reports the completion of a Phase III trial evaluating BAYQ3939 for bacterial pneumonia. It includes assessments of safety, efficacy, and pharmacok…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• BAYQ3939

Snippet

Sponsor: Bayer | Conditions: Pneumonia | Phase 3 | Status: COMPLETED